The Nonalcoholic Steatohepatitis Conference is dedicated to the latest trends and developments in Nonalcoholic Steatohepatitis, examining the latest research and development in diagnosis, pathogenesis and treatment of the disease.
Topics
- Challenges in the diagnosis and therapy of NASH
- Novel biomarkers, diagnostic tools, in vivo liver models
- NASH clinical trials
- Preclinical & translational targets for treatment of NASH/ fibrosis
- Role of liver fibrosis in NASH
- Recent updates in NASH pathogenesis
- Cutting edge therapeutic options
- Regulatory landscape pathways
Who should Attend
- Lab teams
- Clinicians
- Translational Researchers
- Hepatologists
- Gastroenterologists
- Clinical Pathologists
- Directors, VPs, Managers and Heads from Biotech, Pharmaceuticals and Healthcare
- Diabetologists
